{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04596592",
            "orgStudyIdInfo": {
                "id": "19-1226"
            },
            "secondaryIdInfos": [
                {
                    "id": "1K23HL151868-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1K23HL151868-01"
                }
            ],
            "organization": {
                "fullName": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "briefTitle": "Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth",
            "officialTitle": "Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth",
            "acronym": "PUBERTY",
            "therapeuticArea": [
                "Other"
            ],
            "study": "pubertal-blockade-and-estradiol-effects-on-cardiometabolic-health-for-transitioning-youth"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-02-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-09-28",
            "studyFirstSubmitQcDate": "2020-10-20",
            "studyFirstPostDateStruct": {
                "date": "2020-10-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-05-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-05-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls."
        },
        "conditionsModule": {
            "conditions": [
                "Transgenderism",
                "Gender Dysphoria",
                "Insulin Sensitivity"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Optional consent for DNA collection and storage"
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Transgender"
                },
                {
                    "label": "Cisgender"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Insulin sensitivity",
                    "timeFrame": "Change from baseline to 12 months"
                },
                {
                    "measure": "Brachial artery flow mediated dilation",
                    "timeFrame": "Change from baseline to 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Large artery stiffness",
                    "description": "Carotid artery ultrasound",
                    "timeFrame": "Change from baseline to 12 months"
                },
                {
                    "measure": "Cerebrovascular function",
                    "description": "Middle cerebral artery blood flow",
                    "timeFrame": "Change from baseline to 12 months"
                },
                {
                    "measure": "VO2 peak",
                    "timeFrame": "Change from baseline to 12 months"
                },
                {
                    "measure": "Fat mass",
                    "description": "DXA",
                    "timeFrame": "Change from baseline to 12 months"
                },
                {
                    "measure": "Fat-free mass",
                    "description": "DXA",
                    "timeFrame": "Change from baseline to 12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria (transgender females):\n\n* Identify as a transgender female\n* Age 13-16 years at the time of enrollment\n* If on a gonadotropin releasing hormone analogue, \\> 6 months exposure\n* Plan to start estradiol clinically in \\< 4 months\n\nInclusion Criteria (cisgender males and females):\n\n* Males and females ages 13-16 years\n\nExclusion Criteria:\n\n* Cognitive, psychiatric, or physical impairment resulting in inability to tolerate the study procedures\n* Antipsychotic medication use\n* Type 1 or 2 diabetes (by medical history)\n* Polycystic ovarian syndrome (PCOS for cisgender females)\n* Hypertension (resting BP \u2265 140/90 mm/Hg)\n* Weight\\> 400 lbs\n* On oral progesterone medications (including oral progesterone or progestin, combined oral contraceptives or etonogestrel implant)\n* Pregnancy (for cisgender females)",
            "sex": "ALL",
            "minimumAge": "13 Years",
            "maximumAge": "16 Years",
            "stdAges": [
                "CHILD"
            ],
            "studyPopulation": "Transgender and cisgender adolescents",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Natalie Nokoff, MD, MSCS",
                    "role": "CONTACT",
                    "phone": "720-777-3607",
                    "email": "Natalie.Nokoff@childrenscolorado.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Natalie Nokoff, MD, MSCS",
                    "affiliation": "University of Colorado, Denver",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Children's Hospital Colorado",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Natalie Nokoff, MD",
                            "role": "CONTACT",
                            "phone": "720-777-3607",
                            "email": "natalie.nokoff@childrenscolorado.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007333",
                    "term": "Insulin Resistance"
                },
                {
                    "id": "D000068116",
                    "term": "Gender Dysphoria"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006946",
                    "term": "Hyperinsulinism"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000020018",
                    "term": "Sexual Dysfunctions, Psychological"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M227",
                    "name": "Gender Dysphoria",
                    "asFound": "Gender Dysphoria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10370",
                    "name": "Insulin Resistance",
                    "asFound": "Insulin Sensitivity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9997",
                    "name": "Hyperinsulinism",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21873",
                    "name": "Sexual Dysfunctions, Psychological",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M266279",
                    "name": "Estradiol 17 beta-cypionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M266280",
                    "name": "Estradiol 3-benzoate",
                    "relevance": "LOW"
                },
                {
                    "id": "M8108",
                    "name": "Estradiol",
                    "relevance": "LOW"
                },
                {
                    "id": "M234941",
                    "name": "Polyestradiol phosphate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}